Fatma Yurt | Nanomedicine | Best Researcher Award

Published on by ScienceFather

Prof. Dr. Fatma Yurt | Nanomedicine | Best Researcher Award

Ege University | Turkey

Prof. Dr. Fatma Yurt is a Professor at the Institute of Nuclear Sciences, Ege University, İzmir, Türkiye, where she serves as Coordinator of the Nuclear Applications Program and has previously directed the Institute. She earned her B.Sc. in Chemistry and her Ph.D. in Nuclear Sciences, both from Ege University, and has become a leading academic and researcher in radiopharmacy, nuclear medicine, pharmaceutical technology, radiation shielding, photodynamic therapy, and imaging of infections and cancers. Her pioneering work bridges fundamental nuclear sciences with translational medical applications, with a particular focus on radiopharmaceuticals, radionuclide diagnostics, and innovative therapeutic strategies for cancer and other diseases. Prof. Yurt has published 133 documents, which have been cited 1,613 times across 1,208 documents, achieving an h-index of 22, reflecting her strong international research impact. Her recent research has explored multifunctional nanomaterials, targeted drug delivery systems, and hybrid therapeutic-imaging platforms that integrate photothermal, photodynamic, and chemotherapeutic effects, underscoring her interdisciplinary approach to advancing nuclear applications in medicine. She has also contributed significantly to the development of novel radiolabeling techniques, biosensing strategies, and in vitro and in vivo evaluation methods, demonstrating a commitment to both basic and applied science. In addition to her extensive research contributions, she is a dedicated educator and mentor, fostering the next generation of scientists while contributing to academic leadership, curriculum development, and international collaborations at Ege University, ensuring the growth and global recognition of nuclear sciences research in Türkiye.

Profile: Scopus | Orcid

Featured Publications

  • Kaya, G., Tunçel, A., Özel, D., Sert, B., Harputlu, E., Ünlü, C. G., Ocakoglu, K., & Yurt, F. (2025). Fucoidan-functionalized molybdenum carbide nanospheres for combined therapy: Photothermal, photodynamic, and chemotherapeutic effects on triple-negative breast cancer cell lines. International Journal of Biological Macromolecules.

  • Özel, D., & Yurt, F. (2025). Synthesis and characterization of manganese-loaded core-shell SPIONs for dual T1/T2 weighted MR imaging applications in breast cancer. Inorganic Chemistry Communications.

  • Özel, D., Tunçel, A., Kaya, G., Sert, B., Yilmaz, O., Aktas, S., Kolatan, H. E., Gokbayrak, Ö., Ünlü, C. G., & Yurt, F. (2025). Targeted therapy for glioblastoma: Synergistic effects of GO/C-TMZ,@, PmAb and magnetic hyperthermia. ACS Applied Bio Materials.

  • Tunçel, A., Sert, B., Özel, D., Kaya, G., Harputlu, E., Ünlü, C. G., Güleç, S., Yurt, F., & Ocakoglu, K. (2025). Enhanced glioblastoma treatment via carbon-coated perovskite nanohybrid: Synergistic effects of targeted chemotherapy and magnetic hyperthermia. Journal of Drug Delivery Science and Technology.

  • Özel, D., Sarıkahya, N. B., Tunçel, A., Nalbantsoy, A., & Yurt, F. (2025). Preparation and biodistribution of [131I]iodoelmalienoside a, a saponin-based adjuvant, in mice. Journal of Radioanalytical and Nuclear Chemistry.

  • Kaya, G., Tunçel, A., Özel, D., Sert, B., Harputlu, E., Ünlü, C. G., Ocakoglu, K., & Yurt, F. (2025). Assessment of Mo₂C@C@Fuc/Mo₂C-MXene@Fuc hybrid structures: Potential for photothermal and photodynamic applications. Surfaces and Interfaces.

  • Sezgin, E., Camgöz, B., & Yurt, F. (2025). Radiation dosimetry in 68Ga-PSMA PET/CT prostate imaging. Journal of Radioanalytical and Nuclear Chemistry.

  • Sert, B., Kaya, G., Çiçek, S., Harputlu, E., Şimşek, T., Tekgül, A., Ünlü, C. G., Yurt, F., & Ocakoglu, K. (2025). Influence of silane coating and graphene oxide integration on the magnetothermal behaviors of La1-xSrxMnO3 nanoparticles. Journal of Magnetism and Magnetic Materials.

Yi Yao | Nanomedicine | Best Researcher Award

Published on by ScienceFather

Prof. Yi Yao | Nanomedicine | Best Researcher Award

Renmin Hospital of Wuhan University | China

Prof. Yi Yao is a distinguished oncologist, Ph.D., Chief Physician, and Director of the Cancer Center at Renmin Hospital of Wuhan University, China, with a career dedicated to advancing cancer treatment and research. He earned his medical degree and doctorate from Wuhan University and received international training as a Visiting Scholar at the German Cancer Research Center, Heidelberg University, and MD Anderson Cancer Center in the United States. His clinical and research interests focus on tumor radiotherapy and the tumor immune microenvironment, with particular emphasis on how irradiation influences tumor biology, radiotherapy efficacy, and radiation-induced lung injury, including the role of fibroblasts and tumor interstitial fibrosis in treatment outcomes. Prof. Yao has secured major research funding from the National Natural Science Foundation of China, the Hubei Natural Science Foundation, and multiple institutional projects, while building collaborations with world-leading cancer research centers in Germany and the United States. He has published extensively in high-impact journals such as Nature Communications, The EMBO Journal, Journal of Clinical Oncology, Cancer Medicine, Histopathology, Nano Letters, and Frontiers in Immunology, in addition to co-editing oncology volumes and holding software copyrights. Recognized with numerous national, provincial, and institutional awards for his contributions to research, clinical practice, and mentorship, Prof. Yao serves on national and provincial oncology committees, is a member of ASCO and ESMO, and continues to mentor doctoral and master’s students, making lasting contributions to oncology education, clinical innovation, and cancer research.

Profile: Orcid

Featured publications

  • Zhang, H., Chen, L., Li, L., Liu, Y., Das, B., Zhai, S., Tan, J., Jiang, Y., Turco, S., Yao, Y., & Frishman, D. (2025). Prediction and analysis of tumor infiltrating lymphocytes across 28 cancers by TILScout using deep learning. NPJ Precision Oncology, 9(1), 76.

  • Dong, Y., Khan, L., & Yao, Y. (2024). Immunological features of EGFR-mutant NSCLC and clinical practice. Journal of the National Cancer Center, 4(4), 289–298.

  • Yi, L., Wen, Y., Xiao, M., Yuan, J., Ke, X., Zhang, X., Khan, L., Song, Q., & Yao, Y. (2024). The proportion of tumour stroma predicts response to immune checkpoint inhibitor plus chemotherapy in stage IIIB–IV NSCLC. Histopathology, 85(2), 295–309.

  • Yao, Y., Shen, Y., Yao, J. C., & Zuo, X. (2024). Editorial: New advancement in tumor microenvironment remodeling and cancer therapy. Frontiers in Cell and Developmental Biology, 12, 1384567.

  • Li, Y., Chen, J., Wang, B., Xu, Z., Wu, C., Ma, J., Song, Q., Geng, Q., Yu, J., Pei, H., & Yao, Y. (2023). FOXK2 affects cancer cell response to chemotherapy by promoting nucleotide de novo synthesis. Drug Resistance Updates, 67, 100926.

  • Yao, Y., Chu, Y., & Xu, B. (2019). Radiotherapy after surgery has significant survival benefits for patients with triple-negative breast cancer. Cancer Medicine, 8(2), 554–563.

Hanghang Liu | Nanomedicine | Women Researcher Award

Published on by ScienceFather

Prof. Dr. Hanghang Liu | Nanomedicine | Women Researcher Award

Assistant Professor at China Three Gorges University | China

Prof. Dr. Hanghang Liu is an accomplished Associate Professor at China Three Gorges University, with expertise in nanomedicine, molecular imaging, and targeted drug delivery. Her academic foundation blends chemistry and preclinical medicine, enabling her to develop multifunctional nanomaterials for the diagnosis and treatment of complex diseases such as Parkinson’s disease and breast cancer. She has made significant research contributions published in high-impact journals. In addition to her research achievements, she actively mentors graduate students in the development of natural product-based nanomedicine, promoting interdisciplinary innovation in biomedical science. Prof. Liu’s work stands at the intersection of fundamental research and clinical translation, making her a leading figure in the advancement of therapeutic nanotechnologies.

Professional Profile

Scopus Profile

Education

Prof. Dr. Hanghang Liu has a strong and interdisciplinary academic foundation in chemistry and biomedical sciences. She began her academic journey at the School of Chemistry and Chemical Engineering, Henan Normal University, where she developed a solid grounding in chemical principles and research methodologies. She then advanced her studies at the Laboratory of Molecular Imaging and Nuclear Medicine at Soochow University, where she completed a doctoral degree in Chemistry with a focus on multifunctional metal nanoprobes for the diagnosis and treatment of breast cancer. Continuing in the same laboratory, she further specialized in preclinical medicine, exploring the application of multifunctional nanomaterials for the treatment of Parkinson’s disease. Her academic path reflects a seamless integration of chemistry, nanotechnology, and translational medicine, which serves as the backbone of her pioneering research in nanomedicine.

Experience

Prof. Dr. Hanghang Liu has cultivated a distinguished career in nanomedicine and molecular imaging through a combination of research, teaching, and mentorship. She currently serves as an Associate Professor at China Three Gorges University, where she leads research efforts in the development and application of natural product-based nanomedicine. In this role, she supervises six master’s students and contributes to the advancement of interdisciplinary research in the Natural Products Research and Utilization Laboratory. Prior to this, she gained valuable experience as a Research Assistant at Soochow University’s Laboratory of Molecular Imaging and Nuclear Medicine, where she was deeply involved in cutting-edge projects related to nanoparticle-based diagnostics and therapeutics for neurodegenerative diseases and cancer. Throughout her professional journey, Prof. Liu has demonstrated a strong commitment to innovation and academic excellence, consistently contributing to high-impact research and nurturing future scientific talent.

Research Interests

Prof. Dr. Hanghang Liu’s research interests lie at the intersection of nanotechnology, molecular imaging, and biomedical applications. She focuses on the design and development of multifunctional nanomaterials for the diagnosis and treatment of neurodegenerative diseases, particularly Parkinson’s disease, and various cancers such as breast cancer. Her work emphasizes the use of metal-based nanoprobes, biomimetic nanoparticles, and natural product-derived nanomedicine to enhance therapeutic efficacy and targeting precision. Additionally, she is interested in the mechanisms of autophagy, oxidative stress modulation, and immune activation through nanoplatforms. Her research aims to bridge fundamental science with clinical application, advancing the field of translational nanomedicine.

Publications

Inhibiting Immune Crosstalk by Modulation of the Intracellular Function and Extracellular Environment of Diseased Microglia to Boost Parkinson’s Disease Therapy

Recent Advance in Sensitive Detection of Demethylase FTO

The Label- and Laser-Free Autocatalytic Nucleic Acid Amplification Reaction for the Sensitive miRNA Detection

Hijacking Endogenous Iron to Amplify Lysosomal-Mitochondrial Cascade Damage for Boosting Anti-Tumor Immunotherapy

Conclusion

Prof. Dr. Hanghang Liu is a highly suitable and deserving candidate for the Research for Women Researcher Award. Her pioneering work in developing multifunctional nanoprobes for the diagnosis and therapy of complex diseases like Parkinson’s and breast cancer showcases her as a forward-thinking and impactful researcher. With continued efforts toward global engagement and outreach, she is well-poised to shape the future of nanomedicine and inspire women in science worldwide.

 

Prof. Kang-Ho Choi | Nanotherapy Awards | Best Researcher Award

Published on by ScienceFather

Prof. Kang-Ho Choi | Nanotherapy Awards | Best Researcher Award

Prof. Kang-Ho Choi, Chonnam National University Medical School and Hospital, South Korea

Dr. Kang-ho Choi is an esteemed Associate Professor in the Department of Neurology at Chonnam National University Hospital, Gwangju, Korea. He earned his M.D. from Chonnam National University Medical School in 2005, followed by a Ph.D. from the same institution in 2011. Dr. Choi completed extensive postgraduate training, including fellowships at Hanyang University Medical Center and Bristol University. His research and clinical expertise focus on neurology, with notable contributions in stroke and neurodegenerative diseases. Dr. Choi has received numerous awards for his research and clinical excellence, including multiple “Best Investigator” and “Best Poster Presentation” awards. He is a member of various professional organizations, including the Korean Neurological Association and the American Heart Association/American Stroke Association.

Professional Profile:

Scopus

Evaluation of Kangho Choi, M.D., Ph.D. for the Best Researcher Award

Summary of Suitability for Award:

Dr. Kangho Choi is a distinguished researcher in the field of neurology with an impressive track record of achievements that make him a highly suitable candidate for the Best Researcher Award

🎓Education:

Dr. Kang-ho Choi completed his medical education at Chonnam National University Medical School in Gwangju, Korea, where he earned his M.D. degree from March 1999 to February 2005. He continued his academic journey at Chonnam National University Graduate School, obtaining his Master’s degree (M.S.) from March 2006 to February 2008, and later his Ph.D. from March 2009 to February 2011.

🏢Work Experience:

Dr. Kang-ho Choi has held several key positions in his career. Since November 2016, he has been serving as an Associate Professor in the Department of Neurology at Chonnam National University Hospital in Gwangju, Korea. Prior to this role, he was an Assistant Professor in the same department from March 2011 to October 2016. Dr. Choi completed his Clinical Fellowship at Chonnam National University Hospital from March 2010 to February 2011, and also undertook Research Fellowships at Hanyang University Medical Center in Seoul, Korea, from November 2010 to December 2010, and at the School of Clinical Sciences, Bristol University in the United Kingdom, from March 2013 to June 2013. His foundational training includes a Residency in Neurology at Chonnam National University Hospital from March 2006 to February 2010 and a Medical Internship at the same institution from March 2005 to February 2006.

🏅Awards:

Dr. Kang-ho Choi has received numerous prestigious awards throughout his career, reflecting his significant contributions to neurology. He was honored with the Best Investigator Award from Chonnam National University Hospital in December 2019 and May 2022. Additionally, he received the Break-through of the Year award from KHIDI of Korea in December 2017 and from the NRF of Korea in December 2020. In July 2017, he earned the Young Investigator Award at the Hwasun Biomedical Workshop. Dr. Choi’s excellence in research presentations is highlighted by multiple Best Poster Presentation Awards, including those from the ICSU & ICAS Joint Conference in September 2016, the ICSU 2018 & 1st AKJSC Joint Conference in September 2018, Stroke Update 2023 & 11th JKJSC in November 2023, and APSC 2023 in December 2023. His accolades also include the Best Presentation Award at the 35th Conference of KNA in November 2016, the Best Article award at the Annual Meeting of the Korean Neurological Association in October 2009, and the Best Doctor of the Year award from Chonnam National University Hospital in February 2010. Earlier in his career, he was recognized as the Best Resident of the Year by The Korean Intern Resident Association in February 2007.

Publication Top Notes:

  • Focused Magnetic Stimulation for Motor Recovery After Stroke
  • Treatment of Ischemic Stroke by Atorvastatin-Loaded PEGylated Liposome
  • Secular Trends in Outcomes and Impact of Novel Oral Anticoagulants in Atrial Fibrillation-Related Acute Ischemic Stroke
  • Contemporary Statistics of Acute Ischemic Stroke and Transient Ischemic Attack in 2021: Insights From the CRCS-K-NIH Registry
  • Erratum: Corrigendum to “D-dimer to Fibrinogen Ratio Predicts Early Neurological Deterioration in Ischemic Stroke with Atrial Fibrillation”

 

 

 

Dr. Fernando Novio | Nanodrugs Awards | Best Researcher Award

Published on by ScienceFather

Dr. Fernando Novio | Nanodrugs Awards | Best Researcher Award

Dr. Fernando Novio | Nanodrugs Awards | Best Researcher Award

Fernando Novio is an Associate Professor in the Chemistry Department at Universitat Autónoma de Barcelona (UAB). Born on May 5th, 1976, he holds a BSc in Chemistry (2000) and a Master’s degree (2002) from the University of Santiago de Compostela, and a Ph.D. in Chemistry from UAB (2007). His research expertise lies in the field of Inorganic Chemistry, with a focus on Bioinorganic and Nanomedicine. He has held postdoctoral positions at the Laboratoire de Chimie de Coordination in Toulouse and the Catalan Institute of Nanoscience and Nanotechnology (ICN2-CSIC). In December 2022, he secured a permanent position at UAB, where he leads a research group specializing in the development of nanostructured coordination polymers for therapeutic and diagnostic applications, particularly in brain diseases. Over his career, Novio has published 58 scientific papers, presented over 100 communications at conferences, and contributed to several European projects and patents. His work is widely recognized, with an h-index of 25 and approximately 1,400 citations. He has also been an editor of a scientific book and regularly reviews for prestigious journals.

Professional Profile:

Scopus

Google Scholar

Suitability Summary for Best Researcher Award:

Summary of Suitability: Dr. Fernando Novio is a highly qualified candidate for the Best Researcher Award, given his extensive academic background, research experience, and significant contributions to the fields of Inorganic Chemistry, Bioinorganic Chemistry, and Nanomedicine. His educational journey, beginning with a BSc in Chemistry (2000) and a Master’s degree (2002) from the University of Santiago de Compostela, culminated in a Ph.D. in Chemistry from Universitat Autónoma de Barcelona (UAB) in 2007. This strong foundation has enabled him to excel in his research career, particularly in developing coordination polymers for therapeutic and diagnostic applications, with a focus on brain diseases.

🎓Education:

Fernando Novio completed his BSc in Chemistry in 2000, followed by a Master’s degree in Chemistry in 2002, both from the University of Santiago de Compostela. He later pursued his Ph.D. in Chemistry at Universitat Autónoma de Barcelona (UAB), which he successfully completed in 2007.

🏢Work Experience:

After earning his Ph.D. in Chemistry, Fernando Novio undertook a postdoctoral position at the Laboratoire de Chimie de Coordination in Toulouse, France, where he worked from 2008 to 2011. He then continued his research as a postdoctoral researcher at the Catalan Institute of Nanoscience and Nanotechnology (ICN2-CSIC) in Barcelona, Spain, from 2011 to 2022. In December 2022, he was appointed as an Associate Professor in the Chemistry Department at Universitat Autónoma de Barcelona (UAB).

🏆Awards:

Fernando Novio has been honored with the Best Researcher Award at the International Research Awards, recognizing his significant contributions to the field. Additionally, he has received recognition for his work in Nanomedicine and Bioinorganic Chemistry, further highlighting his impact and achievements in these specialized areas of research.

Publication Top Notes:

  • Comparative study of frequency-dependent dielectric properties of ferrites MFe2O4 (M = Co, Mg, Cr and Mn) nanoparticles
    • Cited by: 58
  • NiFe2O4 nanoparticles/MWCNTs nanohybrid as anode material for lithium-ion battery
    • Cited by: 57
  • Nanohybrids of multi-walled carbon nanotubes and cobalt ferrite nanoparticles: High performance anode material for lithium-ion batteries
    • Cited by: 24
  • Nanocomposites of multi-walled carbon nanotubes/cobalt ferrite nanoparticles: synthesis, structural, dielectric and impedance spectroscopy
    • Cited by: 20
  • Annealing Induced Enhancement in Magnetic Properties of Co0.5Zn0.5Fe2O4 Nanoparticles
    • Cited by: 14